首页 > 最新文献

International Journal of Urology最新文献

英文 中文
Editorial Comment on Underactive bladder as defined by the International Continence Society in the 2023 Japan Community Health Survey. 关于国际尿失禁协会在 2023 年日本社区健康调查中定义的膀胱功能不全的编辑评论。
IF 1.8 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-28 DOI: 10.1111/iju.15623
Tomohiro Matsuo, Ryoichi Imamura
{"title":"Editorial Comment on Underactive bladder as defined by the International Continence Society in the 2023 Japan Community Health Survey.","authors":"Tomohiro Matsuo, Ryoichi Imamura","doi":"10.1111/iju.15623","DOIUrl":"https://doi.org/10.1111/iju.15623","url":null,"abstract":"","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142521904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment for "Clinical manifestations of patients with interstitial cystitis and bladder pain syndrome using a patient registry in Japan". 为 "利用日本患者登记册了解间质性膀胱炎和膀胱疼痛综合征患者的临床表现 "发表的编辑评论
IF 1.8 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-28 DOI: 10.1111/iju.15627
Hisae Nishii
{"title":"Editorial Comment for \"Clinical manifestations of patients with interstitial cystitis and bladder pain syndrome using a patient registry in Japan\".","authors":"Hisae Nishii","doi":"10.1111/iju.15627","DOIUrl":"https://doi.org/10.1111/iju.15627","url":null,"abstract":"","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142521903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival improvement over time in renal cell carcinoma treated with nephrectomy: A longitudinal propensity score-matched study. 肾切除术治疗肾细胞癌的生存率随时间推移而提高:倾向评分匹配纵向研究。
IF 1.8 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-28 DOI: 10.1111/iju.15610
Kenjiro Kishitani, Satoru Taguchi, Koji Tanaka, Tetsuya Danno, Takahiro Oshina, Yoichi Fujii, Jun Kamei, Yoshiyuki Akiyama, Shigenori Kakutani, Yusuke Sato, Yuta Yamada, Aya Niimi, Daisuke Yamada, Haruki Kume

Objective: Surgical treatment for renal cell carcinoma (RCC) has drastically evolved for the past 30 years. However, survival outcomes of RCC according to times have not been fully elucidated, especially in the real-world setting. This study aimed to assess the survival improvement over time in RCC treated with nephrectomy by analyzing a longitudinal cohort using propensity score matching (PSM).

Methods: We retrospectively reviewed 960 patients with RCC who underwent radical or partial nephrectomy between 1981 and 2018. Patients were divided into two groups according to the time of surgery (1981-1999 vs. 2000-2018). Using PSM, overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) were compared between the two groups.

Results: Overall, 255 and 705 patients underwent surgery in the earlier (1981-1999) and recent (2000-2018) eras, and PSM derived a matched cohort of 466 patients (233 patients per each group). All patients in the earlier era cohort received open surgeries, whereas about a half (47.4%) of patients in the recent era cohort received minimally-invasive (laparoscopic/robotic) surgeries. After PSM, 137 (29.4%) patients developed recurrence, 105 (22.5%) died of RCC, and 113 (24.2%) died from other causes, with a median follow-up period of 90 months. The recent era cohort had significantly longer OS, CSS, and RFS than the earlier era cohort.

Conclusions: Patients with RCC treated in the recent era (2000-2018) showed significantly longer survival than those treated in the earlier era (1981-1999). The improved survival might be attributable to the prevalence of minimally-invasive (laparoscopic/robotic) surgeries.

目的:在过去的 30 年中,肾细胞癌(RCC)的手术治疗发生了翻天覆地的变化。然而,RCC 随时间变化的生存结果尚未完全阐明,尤其是在现实世界中。本研究旨在通过使用倾向评分匹配(PSM)分析纵向队列,评估接受肾切除术治疗的 RCC 随时间推移的生存率改善情况:我们回顾性研究了1981年至2018年间接受根治性或部分肾切除术的960例RCC患者。根据手术时间(1981-1999年与2000-2018年)将患者分为两组。使用PSM比较两组患者的总生存期(OS)、癌症特异性生存期(CSS)和无复发生存期(RFS):总体而言,早期(1981-1999 年)和近期(2000-2018 年)分别有 255 名和 705 名患者接受了手术,PSM 得出了 466 名患者的匹配队列(每组 233 名患者)。早期队列中的所有患者都接受了开腹手术,而近期队列中约有一半(47.4%)的患者接受了微创(腹腔镜/机器人)手术。PSM术后,137例(29.4%)患者复发,105例(22.5%)死于RCC,113例(24.2%)死于其他原因,中位随访时间为90个月。近代队列的OS、CSS和RFS明显长于早期队列:结论:近期(2000-2018 年)接受治疗的 RCC 患者的生存期明显长于早期(1981-1999 年)接受治疗的患者。生存率的提高可能与微创(腹腔镜/机器人)手术的普及有关。
{"title":"Survival improvement over time in renal cell carcinoma treated with nephrectomy: A longitudinal propensity score-matched study.","authors":"Kenjiro Kishitani, Satoru Taguchi, Koji Tanaka, Tetsuya Danno, Takahiro Oshina, Yoichi Fujii, Jun Kamei, Yoshiyuki Akiyama, Shigenori Kakutani, Yusuke Sato, Yuta Yamada, Aya Niimi, Daisuke Yamada, Haruki Kume","doi":"10.1111/iju.15610","DOIUrl":"https://doi.org/10.1111/iju.15610","url":null,"abstract":"<p><strong>Objective: </strong>Surgical treatment for renal cell carcinoma (RCC) has drastically evolved for the past 30 years. However, survival outcomes of RCC according to times have not been fully elucidated, especially in the real-world setting. This study aimed to assess the survival improvement over time in RCC treated with nephrectomy by analyzing a longitudinal cohort using propensity score matching (PSM).</p><p><strong>Methods: </strong>We retrospectively reviewed 960 patients with RCC who underwent radical or partial nephrectomy between 1981 and 2018. Patients were divided into two groups according to the time of surgery (1981-1999 vs. 2000-2018). Using PSM, overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) were compared between the two groups.</p><p><strong>Results: </strong>Overall, 255 and 705 patients underwent surgery in the earlier (1981-1999) and recent (2000-2018) eras, and PSM derived a matched cohort of 466 patients (233 patients per each group). All patients in the earlier era cohort received open surgeries, whereas about a half (47.4%) of patients in the recent era cohort received minimally-invasive (laparoscopic/robotic) surgeries. After PSM, 137 (29.4%) patients developed recurrence, 105 (22.5%) died of RCC, and 113 (24.2%) died from other causes, with a median follow-up period of 90 months. The recent era cohort had significantly longer OS, CSS, and RFS than the earlier era cohort.</p><p><strong>Conclusions: </strong>Patients with RCC treated in the recent era (2000-2018) showed significantly longer survival than those treated in the earlier era (1981-1999). The improved survival might be attributable to the prevalence of minimally-invasive (laparoscopic/robotic) surgeries.</p>","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142521905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comorbidities in Japanese testicular cancer survivors: A multi-institutional, cross-sectional study. 日本睾丸癌幸存者的合并症:一项多机构横断面研究。
IF 1.8 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-28 DOI: 10.1111/iju.15622
Juntaro Koyama, Shinichi Yamashita, Kenichi Kakimoto, Motohide Uemura, Takeshi Kishida, Koji Kawai, Terukazu Nakamura, Takayuki Goto, Takahiro Osawa, Kazuo Nishimura, Norio Nonomura, Hiroyuki Nishiyama, Takumi Shiraishi, Osamu Ukimura, Osamu Ogawa, Nobuo Shinohara, Yoshimi Suzukamo, Akihiro Ito, Yoichi Arai

Objective: To evaluate comorbidities in Japanese testicular cancer (TC) survivors in a multi-institutional, cross-sectional study.

Methods: This study enrolled TC survivors who visited any of the eight high-volume institutions in Japan from 2018 to 2019. After obtaining informed consent, participants answered questionnaires about their comorbidities. We analyzed the impact of treatment on comorbidities rate in TC survivors.

Results: A total of 509 TC survivors responded to the comorbidity questionnaires. Median age at the time of response was 43 years (IQR 35-51 years) and median follow-up period after treatment was 5.1 years (IQR 2.1-9.2 years). TC survivors were divided according to the number of cycles of chemotherapy into the following groups: None (n = 153); 1-2 cycles (n = 34); 3-4 cycles (n = 234); or ≥5 cycles (n = 88). The prevalence of kidney disease increased significantly with increasing number of cycles of chemotherapy (p < 0.05). The relative risk of cardiovascular disease in the groups with three or more cycles was 2.6 compared to the group without chemotherapy.

Conclusion: The present study showed that the prevalence of kidney disease in TC survivors was increased with increasing number of cycles of chemotherapy.

目的:在多机构横断面研究中评估日本睾丸癌(TC)幸存者的合并症:在一项多机构横断面研究中评估日本睾丸癌(TC)幸存者的合并症:本研究招募了 2018 年至 2019 年期间在日本八家高流量机构中的任何一家就诊的 TC 幸存者。在获得知情同意后,参与者回答了有关其合并症的问卷。我们分析了治疗对TC幸存者合并症发生率的影响:共有 509 名 TC 幸存者回答了合并症问卷。回答时的中位年龄为 43 岁(IQR 35-51 岁),治疗后的中位随访时间为 5.1 年(IQR 2.1-9.2 年)。TC 幸存者根据化疗周期数分为以下几组:无(n = 153);1-2 个周期(n = 34);3-4 个周期(n = 234);或≥5 个周期(n = 88)。随着化疗周期数的增加,肾脏疾病的患病率明显增加(p 结论:化疗周期数越多,肾脏疾病的患病率越高:本研究表明,随着化疗周期数的增加,TC 存活者中肾脏疾病的患病率也随之增加。
{"title":"Comorbidities in Japanese testicular cancer survivors: A multi-institutional, cross-sectional study.","authors":"Juntaro Koyama, Shinichi Yamashita, Kenichi Kakimoto, Motohide Uemura, Takeshi Kishida, Koji Kawai, Terukazu Nakamura, Takayuki Goto, Takahiro Osawa, Kazuo Nishimura, Norio Nonomura, Hiroyuki Nishiyama, Takumi Shiraishi, Osamu Ukimura, Osamu Ogawa, Nobuo Shinohara, Yoshimi Suzukamo, Akihiro Ito, Yoichi Arai","doi":"10.1111/iju.15622","DOIUrl":"https://doi.org/10.1111/iju.15622","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate comorbidities in Japanese testicular cancer (TC) survivors in a multi-institutional, cross-sectional study.</p><p><strong>Methods: </strong>This study enrolled TC survivors who visited any of the eight high-volume institutions in Japan from 2018 to 2019. After obtaining informed consent, participants answered questionnaires about their comorbidities. We analyzed the impact of treatment on comorbidities rate in TC survivors.</p><p><strong>Results: </strong>A total of 509 TC survivors responded to the comorbidity questionnaires. Median age at the time of response was 43 years (IQR 35-51 years) and median follow-up period after treatment was 5.1 years (IQR 2.1-9.2 years). TC survivors were divided according to the number of cycles of chemotherapy into the following groups: None (n = 153); 1-2 cycles (n = 34); 3-4 cycles (n = 234); or ≥5 cycles (n = 88). The prevalence of kidney disease increased significantly with increasing number of cycles of chemotherapy (p < 0.05). The relative risk of cardiovascular disease in the groups with three or more cycles was 2.6 compared to the group without chemotherapy.</p><p><strong>Conclusion: </strong>The present study showed that the prevalence of kidney disease in TC survivors was increased with increasing number of cycles of chemotherapy.</p>","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142521902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is seated voiding associated with lower urinary tract symptoms, health conditions, or marital status? Findings by age group from the 2023 Japan Community Health Survey. 坐姿排尿与下尿路症状、健康状况或婚姻状况有关吗?2023 年日本社区健康调查按年龄组划分的结果。
IF 1.8 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-25 DOI: 10.1111/iju.15624
Noritoshi Sekido, Nobuhiro Haga, Kenji Omae, Yasue Kubota, Takahiko Mitsui, Naoya Masumori, Motoaki Saito, Ryuji Sakakibara, Mikako Yoshida, Satoru Takahashi

Objectives: Seated voiding may be an attempt to obviate voiding dysfunction, improve physical stability during voiding, and prevent messy bathroom contamination. Therefore, we hypothesized that seated voiders had a higher prevalence of lower urinary tract symptoms (LUTS), deteriorating health conditions, and a higher marriage rate than standing voiders.

Methods: Of the participants from the 2023 Japan Community Health Survey conducted by the Japanese Continence Society, 2936 men (mean age: 53.6 years old) were divided into sitting and standing groups based on their posture when voiding at home. Characteristics of the two groups were compared, and factors associated with seated voiding stratified by age were investigated using multivariable logistic regression analysis.

Results: One-thousand six-hundred and sixty men (57%) voided in the sitting position at home, and the proportion of seated voiding decreased with age. On multivariable analysis, comorbidities other than benign prostatic hyperplasia were associated with the standing group aged 40-59, and storage symptoms were associated with the seated group aged 60 and older. Being married was significantly and consistently associated with seated voiding across all ages.

Conclusions: Approximately 60% of Japanese men void in the sitting position at home. There are certain differences in the associations of LUTS and health conditions with voiding position by age, while seated voiding is consistently associated with marital status throughout all ages, which implies that sanitation matters.

目的:坐位排尿可能是为了避免排尿功能障碍、提高排尿时的身体稳定性并防止浴室脏乱。因此,我们假设坐着排尿者比站着排尿者有更高的下尿路症状(LUTS)发生率、更差的健康状况和更高的结婚率:方法:在日本尿失禁协会开展的 2023 年日本社区健康调查中,根据在家排尿时的姿势将 2936 名男性(平均年龄:53.6 岁)分为坐姿组和站立组。比较了两组的特征,并使用多变量逻辑回归分析法研究了与坐姿排尿相关的因素(按年龄分层):结果:1660 名男性(57%)在家中以坐姿排尿,坐姿排尿的比例随着年龄的增长而下降。在多变量分析中,除良性前列腺增生症以外的其他合并症与 40-59 岁的站立组有关,而贮尿症状与 60 岁及以上的坐姿组有关。已婚与所有年龄段的坐位排尿都有明显且持续的相关性:结论:约 60% 的日本男性在家中以坐姿排尿。结论:约有 60% 的日本男性在家中以坐姿排尿,不同年龄段的尿路感染和健康状况与排尿姿势的相关性存在一定差异,而坐姿排尿在所有年龄段都与婚姻状况相关,这意味着环境卫生很重要。
{"title":"Is seated voiding associated with lower urinary tract symptoms, health conditions, or marital status? Findings by age group from the 2023 Japan Community Health Survey.","authors":"Noritoshi Sekido, Nobuhiro Haga, Kenji Omae, Yasue Kubota, Takahiko Mitsui, Naoya Masumori, Motoaki Saito, Ryuji Sakakibara, Mikako Yoshida, Satoru Takahashi","doi":"10.1111/iju.15624","DOIUrl":"https://doi.org/10.1111/iju.15624","url":null,"abstract":"<p><strong>Objectives: </strong>Seated voiding may be an attempt to obviate voiding dysfunction, improve physical stability during voiding, and prevent messy bathroom contamination. Therefore, we hypothesized that seated voiders had a higher prevalence of lower urinary tract symptoms (LUTS), deteriorating health conditions, and a higher marriage rate than standing voiders.</p><p><strong>Methods: </strong>Of the participants from the 2023 Japan Community Health Survey conducted by the Japanese Continence Society, 2936 men (mean age: 53.6 years old) were divided into sitting and standing groups based on their posture when voiding at home. Characteristics of the two groups were compared, and factors associated with seated voiding stratified by age were investigated using multivariable logistic regression analysis.</p><p><strong>Results: </strong>One-thousand six-hundred and sixty men (57%) voided in the sitting position at home, and the proportion of seated voiding decreased with age. On multivariable analysis, comorbidities other than benign prostatic hyperplasia were associated with the standing group aged 40-59, and storage symptoms were associated with the seated group aged 60 and older. Being married was significantly and consistently associated with seated voiding across all ages.</p><p><strong>Conclusions: </strong>Approximately 60% of Japanese men void in the sitting position at home. There are certain differences in the associations of LUTS and health conditions with voiding position by age, while seated voiding is consistently associated with marital status throughout all ages, which implies that sanitation matters.</p>","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dutasteride, a 5 alpha reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia. 5α还原酶抑制剂度他雄胺可能与良性前列腺增生患者的炎症加剧有关。
IF 1.8 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-23 DOI: 10.1111/iju.15612
So Inamura, Yusuke Fukiage, Hisato Kobayashi, Manami Tsutsumiuchi, Masaya Seki, Minekatsu Taga, Masato Fukushima, Motohiro Kobayashi, Osamu Yokoyama, Naoki Terada

Background: α-1 blockers and dutasteride are widely used as agents to treat benign prostatic hyperplasia (BPH); the impact of these drugs on prostatic inflammation is still unclear. Herein, we investigated the impact of α-1 blockers and dutasteride treatment of BPH in terms of the degree of prostatic inflammation.

Materials and methods: Tissue specimens were obtained from 143 BPH patients who were administered α-1 blockers up until their operation. Thirty-three of the patients had also been treated with dutasteride before the procedure. The degree of prostatic inflammation was quantified histologically by the ratio of high endothelial venule (HEV)-like vessels. We divided this retrospective cohort into α-1 blocker monotherapy and combination therapy (α-1 blockers + dutasteride) groups and evaluated clinical parameters of the two groups in relation to the degree of chronic prostatic inflammation. At the same time, we assessed factors exacerbating chronic prostatic inflammation.

Results: Comparison of the monotherapy and combination therapy groups showed no significant differences in the parameters of the urodynamic study or degree of chronic prostatic inflammation, whereas the IPSS total score, voiding subscore, nocturia, intermittency, weak stream, and straining were significantly lower in the combination than the monotherapy group. The duration of α-1 blockers administration was not correlated with the ratio of HEV-like vessels, while that of dutasteride was strongly correlated (correlation coefficient = 0.595; p < 0.001). Multiple regression analysis demonstrated that the duration of dutasteride administration was a key factor exacerbating the degree of chronic prostatic inflammation.

Conclusions: The present study showed that despite their ameliorating effect on prostatic hyperplasia, dutasteride contributed significantly to chronic prostatic inflammation.

背景:α-1受体阻滞剂和度他雄胺被广泛用于治疗良性前列腺增生症(BPH),但这些药物对前列腺炎症的影响尚不清楚。在此,我们研究了α-1受体阻滞剂和度他雄胺治疗良性前列腺增生症对前列腺炎症程度的影响:组织标本取自 143 名前列腺增生症患者,这些患者在手术前一直服用α-1 受体阻滞剂。其中 33 名患者在手术前还接受过度他雄胺治疗。前列腺炎症的程度通过高内皮静脉(HEV)样血管的比例进行组织学量化。我们将这一回顾性队列分为α-1受体阻滞剂单药治疗组和联合治疗组(α-1受体阻滞剂+度他雄胺),并评估了两组临床参数与慢性前列腺炎症程度的关系。同时,我们还评估了加重慢性前列腺炎症的因素:结果:单一疗法组和联合疗法组的尿动力学研究参数和慢性前列腺炎症程度比较无显著差异,而联合疗法组的IPSS总分、排尿亚分、夜尿、间歇性排尿、尿流无力和排尿费力均显著低于单一疗法组。α-1受体阻滞剂的用药时间与HEV样血管的比例无关,而度他雄胺的用药时间与HEV样血管的比例密切相关(相关系数=0.595;P 结论:α-1受体阻滞剂与HEV样血管的比例无关,而度他雄胺与HEV样血管的比例密切相关:本研究表明,尽管度他雄胺对前列腺增生有改善作用,但它对慢性前列腺炎症有明显的促进作用。
{"title":"Dutasteride, a 5 alpha reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia.","authors":"So Inamura, Yusuke Fukiage, Hisato Kobayashi, Manami Tsutsumiuchi, Masaya Seki, Minekatsu Taga, Masato Fukushima, Motohiro Kobayashi, Osamu Yokoyama, Naoki Terada","doi":"10.1111/iju.15612","DOIUrl":"https://doi.org/10.1111/iju.15612","url":null,"abstract":"<p><strong>Background: </strong>α-1 blockers and dutasteride are widely used as agents to treat benign prostatic hyperplasia (BPH); the impact of these drugs on prostatic inflammation is still unclear. Herein, we investigated the impact of α-1 blockers and dutasteride treatment of BPH in terms of the degree of prostatic inflammation.</p><p><strong>Materials and methods: </strong>Tissue specimens were obtained from 143 BPH patients who were administered α-1 blockers up until their operation. Thirty-three of the patients had also been treated with dutasteride before the procedure. The degree of prostatic inflammation was quantified histologically by the ratio of high endothelial venule (HEV)-like vessels. We divided this retrospective cohort into α-1 blocker monotherapy and combination therapy (α-1 blockers + dutasteride) groups and evaluated clinical parameters of the two groups in relation to the degree of chronic prostatic inflammation. At the same time, we assessed factors exacerbating chronic prostatic inflammation.</p><p><strong>Results: </strong>Comparison of the monotherapy and combination therapy groups showed no significant differences in the parameters of the urodynamic study or degree of chronic prostatic inflammation, whereas the IPSS total score, voiding subscore, nocturia, intermittency, weak stream, and straining were significantly lower in the combination than the monotherapy group. The duration of α-1 blockers administration was not correlated with the ratio of HEV-like vessels, while that of dutasteride was strongly correlated (correlation coefficient = 0.595; p < 0.001). Multiple regression analysis demonstrated that the duration of dutasteride administration was a key factor exacerbating the degree of chronic prostatic inflammation.</p><p><strong>Conclusions: </strong>The present study showed that despite their ameliorating effect on prostatic hyperplasia, dutasteride contributed significantly to chronic prostatic inflammation.</p>","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is the identity of Gerota fascia? Histological study with cadavers. 格罗塔筋膜的特征是什么?尸体组织学研究。
IF 1.8 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-22 DOI: 10.1111/iju.15596
Yasuyuki Kobayashi, Kohei Edamura, Takuya Sadahira, Yusuke Tominaga, Satoshi Katayama, Takehiro Iwata, Shingo Nishimura, Tomoko Kobayashi, Keita Sato, Takaaki Komiyama, Ryusuke Momota, Hideyo Ohuchi, Motoo Araki

Objectives: The advancement of laparoscopic surgery has allowed surgeons to see finer anatomical structures during surgery. As a result, several issues have arisen regarding Gerota fascia that cannot be explained by previous interpretations, such as its various forms observed during surgery. To address these issues, we histologically examined the structure of Gerota fascia.

Methods: Specimens for study were prepared from kidneys with Gerota fascia from four cadavers, and the structure was studied histologically. Its thickness and collagen fiber area ratios were measured using ImageJ and compared to those of the epimysium of the rectus abdominis muscle.

Results: Connective tissue that appeared to be Gerota fascia was observed in 26 specimens. Histologically, the basic structure of Gerota fascia was a sandwich-like structure with a thin layer of thick, long collagen fibers in the central layer, and small granular collagen fibers scattered at the edges. However, not all areas observed had a similar structure; eight specimens were composed only of small granular collagen fibers. The average thickness of the Gerota fascia was 466 μm, and the area ratio of collagen was 27.1%. In contrast, the epimysium was much thicker than Gerota fascia, and its collagen fibers were much thicker and denser.

Conclusions: Gerota fascia, unlike the epimysium, was a very thin and fragile layer of collagen fibers, and its structure was diverse. This explains why Gerota fascia was observed in various states during surgery. It is important for surgeons to understand the properties of Gerota fascia and to treat it appropriately.

目的:腹腔镜手术的发展使外科医生能够在手术中看到更精细的解剖结构。因此,在 Gerota 筋膜方面出现了一些以前的解释无法解释的问题,如手术中观察到的各种形态。为了解决这些问题,我们从组织学角度研究了Gerota筋膜的结构:研究标本取自四具尸体上带有 Gerota 筋膜的肾脏,并对其结构进行了组织学研究。使用 ImageJ 测量了其厚度和胶原纤维面积比,并与腹直肌上皮层的厚度和胶原纤维面积比进行了比较:结果:在 26 个标本中观察到疑似 Gerota 筋膜的结缔组织。从组织学角度看,格罗塔筋膜的基本结构是一种三明治状结构,中心层是一薄层又粗又长的胶原纤维,边缘散布着细小的颗粒状胶原纤维。不过,并非所有观察到的区域都具有类似的结构;有 8 个样本仅由小颗粒胶原纤维组成。Gerota 筋膜的平均厚度为 466 μm,胶原蛋白的面积比为 27.1%。相比之下,附骨膜的厚度远大于格罗塔筋膜,其胶原纤维也更粗更密:结论:格罗塔筋膜与附膜不同,是一层非常薄且脆弱的胶原纤维层,其结构多种多样。这就解释了为什么在手术过程中能观察到不同状态的 Gerota 筋膜。外科医生必须了解格罗塔筋膜的特性,并对其进行适当处理。
{"title":"What is the identity of Gerota fascia? Histological study with cadavers.","authors":"Yasuyuki Kobayashi, Kohei Edamura, Takuya Sadahira, Yusuke Tominaga, Satoshi Katayama, Takehiro Iwata, Shingo Nishimura, Tomoko Kobayashi, Keita Sato, Takaaki Komiyama, Ryusuke Momota, Hideyo Ohuchi, Motoo Araki","doi":"10.1111/iju.15596","DOIUrl":"https://doi.org/10.1111/iju.15596","url":null,"abstract":"<p><strong>Objectives: </strong>The advancement of laparoscopic surgery has allowed surgeons to see finer anatomical structures during surgery. As a result, several issues have arisen regarding Gerota fascia that cannot be explained by previous interpretations, such as its various forms observed during surgery. To address these issues, we histologically examined the structure of Gerota fascia.</p><p><strong>Methods: </strong>Specimens for study were prepared from kidneys with Gerota fascia from four cadavers, and the structure was studied histologically. Its thickness and collagen fiber area ratios were measured using ImageJ and compared to those of the epimysium of the rectus abdominis muscle.</p><p><strong>Results: </strong>Connective tissue that appeared to be Gerota fascia was observed in 26 specimens. Histologically, the basic structure of Gerota fascia was a sandwich-like structure with a thin layer of thick, long collagen fibers in the central layer, and small granular collagen fibers scattered at the edges. However, not all areas observed had a similar structure; eight specimens were composed only of small granular collagen fibers. The average thickness of the Gerota fascia was 466 μm, and the area ratio of collagen was 27.1%. In contrast, the epimysium was much thicker than Gerota fascia, and its collagen fibers were much thicker and denser.</p><p><strong>Conclusions: </strong>Gerota fascia, unlike the epimysium, was a very thin and fragile layer of collagen fibers, and its structure was diverse. This explains why Gerota fascia was observed in various states during surgery. It is important for surgeons to understand the properties of Gerota fascia and to treat it appropriately.</p>","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment to "Management of apalutamide-induced rash with focus on early peaks". 对 "阿帕鲁胺诱发皮疹的处理,关注早期皮疹高峰 "的编辑评论。
IF 1.8 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-22 DOI: 10.1111/iju.15611
Sayuri Takahashi
{"title":"Editorial Comment to \"Management of apalutamide-induced rash with focus on early peaks\".","authors":"Sayuri Takahashi","doi":"10.1111/iju.15611","DOIUrl":"10.1111/iju.15611","url":null,"abstract":"","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the association between chronic prostatitis and the risk of herpes zoster in a cohort study in Taiwan. 在台湾的一项队列研究中探讨慢性前列腺炎与带状疱疹风险之间的关系。
IF 1.8 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-21 DOI: 10.1111/iju.15605
Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

Objective: The aim of the cohort research was to study the association between chronic prostatitis and the probability of herpes zoster in Taiwan.

Methods: Using the National Health Insurance Research Database (NHIRD) of Taiwan, we selected male persons newly diagnosed with chronic prostatitis aged 20-84 years between 2013 and 2020. These male persons were then matched with a non-prostatitis group who did not have a diagnosis of prostatitis by using 1:1 propensity score matching on age and relevant comorbidities. All participants were observed either until a new diagnosis of herpes zoster was noted or until the completion of the study period in 2020. Cox proportional hazards regression analysis was employed to study the hazard ratio (HR) and 95% confidence interval (CI) for the risk of herpes zoster associated with chronic prostatitis.

Results: A total of 69 239 participants with chronic prostatitis and 69 239 participants with non-prostatitis were included in the analysis. The incidence rate of herpes zoster was higher in participants with chronic prostatitis compared to the non-prostatitis group (8.03 per 1000 person-years for chronic prostatitis group versus 4.74 per 1000 person-years for non-prostatitis group, incidence rate ratio = 1.69, and 95%CI = 1.59-1.81). After adjusting for co-variables, participants with chronic prostatitis were found to have a higher risk of developing herpes zoster compared to the non-prostatitis group (adjusted HR = 1.69, 95%CI = 1.59-1.81, and p < 0.001).

Conclusion: This cohort research suggests that people with chronic prostatitis may have a greater risk of developing herpes zoster compared to the non-prostatitis group in Taiwan. Preventive strategies, such as the administration of the herpes zoster vaccine, might be beneficial in people with chronic prostatitis.

研究目的这项队列研究旨在探讨台湾地区慢性前列腺炎与带状疱疹发病概率之间的关系:方法:我们利用台湾国民健康保险研究数据库(NHIRD),选取了 2013 年至 2020 年间新诊断出患有慢性前列腺炎的 20-84 岁男性。然后,通过年龄和相关合并症的 1:1 倾向性评分匹配,将这些男性患者与未确诊前列腺炎的非前列腺炎患者组进行匹配。对所有参与者进行观察,直到发现新的带状疱疹诊断结果,或直到 2020 年研究期结束。采用考克斯比例危险度回归分析法研究了与慢性前列腺炎相关的带状疱疹风险的危险度比(HR)和95%置信区间(CI):共有69 239名慢性前列腺炎患者和69 239名非前列腺炎患者参与了分析。与非前列腺炎组相比,慢性前列腺炎患者的带状疱疹发病率更高(慢性前列腺炎组为每千人年8.03例,非前列腺炎组为每千人年4.74例,发病率比=1.69,95%CI=1.59-1.81)。调整共同变量后发现,与非前列腺炎组相比,慢性前列腺炎患者罹患带状疱疹的风险更高(调整后 HR = 1.69,95%CI = 1.59-1.81,p 结论:这项队列研究表明,慢性前列腺炎患者罹患带状疱疹的风险比非前列腺炎组高(调整后 HR = 1.69,95%CI = 1.59-1.81,p):这项队列研究表明,在台湾,慢性前列腺炎患者患带状疱疹的风险可能高于非前列腺炎患者。预防策略,如接种带状疱疹疫苗,可能对慢性前列腺炎患者有益。
{"title":"Exploring the association between chronic prostatitis and the risk of herpes zoster in a cohort study in Taiwan.","authors":"Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao","doi":"10.1111/iju.15605","DOIUrl":"https://doi.org/10.1111/iju.15605","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the cohort research was to study the association between chronic prostatitis and the probability of herpes zoster in Taiwan.</p><p><strong>Methods: </strong>Using the National Health Insurance Research Database (NHIRD) of Taiwan, we selected male persons newly diagnosed with chronic prostatitis aged 20-84 years between 2013 and 2020. These male persons were then matched with a non-prostatitis group who did not have a diagnosis of prostatitis by using 1:1 propensity score matching on age and relevant comorbidities. All participants were observed either until a new diagnosis of herpes zoster was noted or until the completion of the study period in 2020. Cox proportional hazards regression analysis was employed to study the hazard ratio (HR) and 95% confidence interval (CI) for the risk of herpes zoster associated with chronic prostatitis.</p><p><strong>Results: </strong>A total of 69 239 participants with chronic prostatitis and 69 239 participants with non-prostatitis were included in the analysis. The incidence rate of herpes zoster was higher in participants with chronic prostatitis compared to the non-prostatitis group (8.03 per 1000 person-years for chronic prostatitis group versus 4.74 per 1000 person-years for non-prostatitis group, incidence rate ratio = 1.69, and 95%CI = 1.59-1.81). After adjusting for co-variables, participants with chronic prostatitis were found to have a higher risk of developing herpes zoster compared to the non-prostatitis group (adjusted HR = 1.69, 95%CI = 1.59-1.81, and p < 0.001).</p><p><strong>Conclusion: </strong>This cohort research suggests that people with chronic prostatitis may have a greater risk of developing herpes zoster compared to the non-prostatitis group in Taiwan. Preventive strategies, such as the administration of the herpes zoster vaccine, might be beneficial in people with chronic prostatitis.</p>","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial comment on the Role of cytoreductive nephrectomy in the era of immune checkpoint inhibitors: A review of current evidence and ongoing trials. 关于《免疫检查点抑制剂时代肾切除术的作用》的编辑评论:当前证据和正在进行的试验综述。
IF 1.8 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-21 DOI: 10.1111/iju.15618
Yusuke Goto
{"title":"Editorial comment on the Role of cytoreductive nephrectomy in the era of immune checkpoint inhibitors: A review of current evidence and ongoing trials.","authors":"Yusuke Goto","doi":"10.1111/iju.15618","DOIUrl":"https://doi.org/10.1111/iju.15618","url":null,"abstract":"","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1